We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEAM icon
326
Atlassian
TEAM
$26.5B
$6.56M 0.03%
41,103
-915
-2% -$166K
AJG icon
327
Arthur J. Gallagher & Co
AJG
$69.1B
$6.52M 0.03%
21,042
-1,249
-6% -$377K
BLDR icon
328
Builders FirstSource
BLDR
$7.29B
$6.44M 0.03%
53,085
+11,891
+29% +$1.58M
KKR icon
329
KKR & Co
KKR
$89.1B
$6.42M 0.03%
49,413
-1,264
-2% -$179K
SHW icon
330
Sherwin-Williams
SHW
$84.8B
$6.36M 0.03%
18,368
-37,327
-67% -$13.2M
MET icon
331
MetLife
MET
$62.4B
$6.33M 0.03%
76,885
-193,802
-72% -$15.3M
VRT icon
332
Vertiv
VRT
$85.7B
$6.3M 0.03%
41,736
+6,929
+20% +$924K
ORLY icon
333
O'Reilly Automotive
ORLY
$75.1B
$6.23M 0.03%
57,768
-2,043
-3% -$205K
VLO icon
334
Valero Energy
VLO
$89.5B
$6.22M 0.03%
36,535
-2,828
-7% -$422K
HIG icon
335
Hartford Financial Services
HIG
$39.9B
$6.21M 0.03%
46,590
+291
+0.6% +$37.3K
ALGN icon
336
Align Technology
ALGN
$12.9B
$6.17M 0.03%
49,263
-9,163
-16% -$1.44M
ZWS icon
337
Zurn Elkay Water Solutions
ZWS
$8.6B
$6.04M 0.03%
128,506
-2,440
-2% -$105K
IRM icon
338
Iron Mountain
IRM
$35.9B
$6.03M 0.03%
59,106
-12,617
-18% -$1.22M
ALB icon
339
Albemarle
ALB
$13.4B
$6.01M 0.03%
+74,170
New +$5.72M
RBLX icon
340
Roblox
RBLX
$35.9B
$5.98M 0.03%
43,168
+5,766
+15% +$717K
TNGX icon
341
Tango Therapeutics
TNGX
$4.21B
$5.95M 0.03%
708,812
SOLV icon
342
Solventum
SOLV
$15.3B
$5.91M 0.03%
80,975
+26,481
+49% +$1.94M
HALO icon
343
Halozyme
HALO
$9.88B
$5.87M 0.03%
79,983
-7,439
-9% -$494K
ES icon
344
Eversource Energy
ES
$28.1B
$5.81M 0.03%
81,713
+2,881
+4% +$189K
COHR icon
345
Coherent
COHR
$43.4B
$5.76M 0.03%
53,439
STT icon
346
State Street
STT
$48.4B
$5.69M 0.03%
49,055
+7,381
+18% +$824K
GDDY icon
347
GoDaddy
GDDY
$13.9B
$5.66M 0.03%
41,350
-15,111
-27% -$2.33M
NDAQ icon
348
Nasdaq
NDAQ
$53.4B
$5.65M 0.03%
63,889
+557
+0.9% +$51.6K
MRNA icon
349
Moderna
MRNA
$21.6B
$5.62M 0.03%
217,604
-3,382
-2% -$94.3K
PEG icon
350
Public Service Enterprise Group
PEG
$38.7B
$5.56M 0.03%
66,661
+1,377
+2% +$116K

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.